Evelo Biosciences, Inc. (EVLO) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	47.9	68.4	68.9	77.8	93.1	38.2	15.5
Short-term investments					54.8
Other current assets	3.6	2.6	2.1	3.2	3.7	0.5	0.2
Total current assets	51.6	71.0	71.0	81.0	151.6	38.8	15.7
Property, plant, and equipment, net	4.8	6.6	7.5	8.3	6.9	3.5	2.5
Other fixed assets	1.2	1.3	1.4	1.6	1.3	1.5	0.3
Total assets	64.4	87.9	90.6	90.9	159.9	43.8	18.6

Accounts payable	1.8	1.6	1.4	0.6	1.5	1.4	0.6
Accrued expenses	7.9	13.1	16.3	8.8	5.0	2.2	0.4
Short-term debt	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other current liabilities	2.7	2.7	2.1	0.4	2.8	0.2	1.2
Total current liabilities	12.4	17.4	19.8	9.7	9.2	3.8	2.2
Long-term debt	43.6	46.6	30.0	19.6	12.3	10.0	9.9
Other liabilities	13.4	15.3	10.3	1.3	1.4	1.0	0.9
Total liabilities	69.4	79.2	60.2	30.7	22.9	14.8	13.0

Shareholders' equity [+]	-5.0	8.7	30.5	60.2	136.9	29.0	5.5
Paid-in capital	524.1	423.3	323.0	259.0	250.3	1.7
Retained earnings	-529.2	-414.7	-292.5	-198.9	-113.4	-56.4	-28.3
Tangible shareholders' equity	-5.0	8.7	30.5	60.2	136.9	29.0	5.5